Evidence map›Paper›PMID 24316450›Full record

ArticleBiosensors & bioelectronics2014

Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma.

Philip C Gach, Peter J Attayek, Rebecca L Whittlesey, Jen Jen Yeh, Nancy L Allbritton

Abstract read
In one paragraph

Article in Biosensors & bioelectronics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells.International journal of molecular sciences · 2022
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Philip C GachDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599, United States.
Peter J AttayekJoint Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC 27599, United States; Joint Department of Biomedical Engineering, North Carolina State University, Raleigh, NC 27695, United States.
Rebecca L WhittleseyLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, United States.
Jen Jen YehLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, United States; Department of Surgery, Division of surgical Oncology, University of North Carolina, Chapel Hill, NC 27599, United States; Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, United States.
Nancy L AllbrittonDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599, United States; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC 27599, United States; Joint Department of Biomedical Engineering, North Carolina State University, Raleigh, NC 27695, United States; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, United States; Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, United States. Electronic address: nlallbri@unc.edu.

Funding

PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Temitope O. Keku · 1985 to 2026
$30.5M
Multiplexed Measurement of Kinase Activity in Single Cancer CellsR01CA139599 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ALLBRITTON, NANCY L. · 2009 to 2013
$2.7M
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer TreatmentR01CA140424 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YEH, JEN JEN · 2010 to 2014
$1.5M
Arrays for Cloning Growth Suppressed CellsR01EB012549 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ALLBRITTON, NANCY L. · 2011 to 2013
$1.3M
NCI NIH HHS CA139599NCI NIH HHS CA140424NCI NIH HHS R01 CA139599NCI NIH HHS R01 CA140424NIBIB NIH HHS EB012549NIBIB NIH HHS R01 EB012549NIDDK NIH HHS P30 DK034987
6 · The paper itself

Abstract

Circulating tumor cells (CTCs) are important biomarkers of cancer progression and metastatic potential. The rarity of CTCs in peripheral blood has driven the development of technologies to isolate these tumor cells with high specificity; however, there are limited techniques available for isolating target CTCs following enumeration. A strategy is described to capture and isolate viable tumor cells from whole blood using an array of releasable microstructures termed micropallets. Specific capture of nucleated cells or cells expressing epithelial cell adhesion molecules (EpCAM) was achieved by functionalizing micropallet surfaces with either fibronectin, Matrigel or anti-EpCAM antibody. Surface grafting of poly(acrylic acid) followed by covalent binding of protein A/G enabled efficient capture of EpCAM antibody on the micropallet surface. MCF-7 cells, a human breast adenocarcinoma, were retained on the array surface with 90±8% efficiency when using an anti-EpCAM-coated array. To demonstrate the efficiency of tumor cell retention on micropallet arrays in the presence of blood, MCF-7 cells were mixed into whole blood and added to small arrays (71 mm(2)) coated with fibronectin, Matrigel or anti-EpCAM. These approaches achieved MCF-7 cell capture from ≤10 µL of whole blood with efficiencies greater than 85%. Furthermore, MCF-7 cells intermixed with 1 mL blood and loaded onto large arrays (7171 mm(2)) were captured with high efficiencies (≥97%), could be isolated from the array by a laser-based approach and were demonstrated to yield a high rate of colony formation (≥85%) after removal from the array. Clinical utility of this technology was shown through the capture, isolation and successful culture of CTCs from the blood of mice engrafted with primary human pancreatic tumors. Direct capture and isolation of living tumor cells from blood followed by analysis or culture will be a valuable tool for cancer cell characterization.

Indexed as

AdenocarcinomaAnimalsBiosensing TechniquesCell Line, TumorCell SeparationEquipment DesignFemaleHumansMiceNeoplastic Cells, CirculatingPancreatic NeoplasmsTissue Array AnalysisCell arrayCell sortingCirculating tumor cellsMicrofabricationPancreatic cancerSurface functionalization

Identifiers

PMID24316450
PMCPMC3947965

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.